Drug Development for Inflammatory Bowel Disease: Interaction Among Academia, Industry and Regulatory Authorities

Silvio Danese, Séverine Vermeire

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)S541
JournalJournal of Crohn's & colitis
Volume10 Suppl 2
DOIs
Publication statusPublished - Sep 2016

Keywords

  • Editorial

Cite this

Drug Development for Inflammatory Bowel Disease : Interaction Among Academia, Industry and Regulatory Authorities. / Danese, Silvio; Vermeire, Séverine.

In: Journal of Crohn's & colitis, Vol. 10 Suppl 2, 09.2016, p. S541.

Research output: Contribution to journalArticle

@article{7fb8a9d253154d2babb950d773929db4,
title = "Drug Development for Inflammatory Bowel Disease: Interaction Among Academia, Industry and Regulatory Authorities",
keywords = "Editorial",
author = "Silvio Danese and S{\'e}verine Vermeire",
year = "2016",
month = "9",
doi = "10.1093/ecco-jcc/jjv185",
language = "English",
volume = "10 Suppl 2",
pages = "S541",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Drug Development for Inflammatory Bowel Disease

T2 - Interaction Among Academia, Industry and Regulatory Authorities

AU - Danese, Silvio

AU - Vermeire, Séverine

PY - 2016/9

Y1 - 2016/9

KW - Editorial

U2 - 10.1093/ecco-jcc/jjv185

DO - 10.1093/ecco-jcc/jjv185

M3 - Article

C2 - 27604977

VL - 10 Suppl 2

SP - S541

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

ER -